Global Amnestic Disorders Therapeutics Market to Grow at a CAGR of 5% During 2024-2032, Aided by the Rising Incidences of Amnestic Disorders

The amnestic disorder therapeutic options are in huge demand due to the rising incidences of amnestic disorders across the globe. These disorders are caused by the structural damage to the parts of the brain by head injury or trauma, tumours, stroke, or cerebrovascular diseases. These disorders can also be caused by the chemical changes in the brain due to the excessive intake of alcohol, long-term heavy drug use, and exposure to toxins, such as mercury, carbon monoxide, lead, and certain insecticides. There are many types of amnesia, and among these, the transient global amnesia generally has a brilliant prognosis for recovery.

The market for amnestic disorder therapeutics is expected to grow, owing to the increasing number of accidents (road, air, and water) as this would enhance the likelihood of head injuries, which may result in organic amnesia. Further, the rising ageing population is enhancing the market growth as the older the people get, the more they become susceptible to amnesia as a result of various neurological disorders, such as dementia.

The market is aided by the rising awareness regarding the disease across the globe. The market is led by research and development activities being undertaken by the key players, such as Eisai Co., Ltd. (TYO: 4523) and AbbVie Inc. In 2018, Eisai Co., Ltd., along with Biogen (NASDAQ: BIIB) announced that Biogen had completed the submission for Biologics License Application (BLA) to the U.S. Food and Drug Administration ( FDA) for the approval of aducanumab, an Alzheimer's disease research treatment. Since R&Ds lead to innovations and further enhancement within a field, such undertakings are expected to aid the market growth of amnestic disorder therapeutics.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Diseases Type, Drug Type, Route of Administration, Distribution Channel, End User, and Region:

• The amnestic disorders therapeutics industry, on the basis of diseases type, is divided into anterograde amnesia, retrograde amnesia, transient global amnesia, and infantile amnesia, among others.

• Based on drug type, the market is segmented into cholinesterase inhibitors and memantine, among others.

• On the basis of route of administration, the market is segregated into oral and injectable.

• Based on distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and online, among others.

• On the basis of end users, the industry is categorised into hospitals, special clinics, and home care, among others.

• Regionally, the market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The global market for amnestic disorders therapeutics is being driven by the inflating disposable income of the population.

• The market is further aided by the rising geriatric population, who are more susceptible to showcase amnestic disorders.

• Further, the increasing incidences of amnesia across the world are enhancing the market growth.

• Factors such as high diagnosis rate, favourable reimbursement scenario, high disposable incomes, the availability of a large number of hospitals, and very well-developed healthcare infrastructure within developed regions, such as North America and Europe, will invigorate the market growth.

Key Offerings of the Report:

• The EMR report gives an overview of the global market for amnestic disorders therapeutics for the periods (2018-2023) and (2024-2032).

• The report also offers the historical (2018-2023) and forecast (2024-2032) markets for the diseases types, drug types, routes of administration, distribution channels, end users, and regional markets of amnestic disorders therapeutics.

• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

Eisai Co., Ltd., AbbVie Inc, Novartis AG, and Johnson & Johnson Services, Inc., among others, are the key players in the global amnestic disorders therapeutics market. The EMR report looks into the capacity, market share, and latest developments of these major players like plant turnarounds, mergers and acquisitions, and capacity expansions.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.